コハク酸ドキシラミンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Doxylamine Succinate Market Insights, Forecast to 2028

• レポートコード：QY2207C0161 • 出版社/出版日：QYResearch / 2022年7月15日 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のコハク酸ドキシラミンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にコハク酸ドキシラミンの世界市場のxxx％を占める「固体」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「抗ヒスタミン薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のコハク酸ドキシラミンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのコハク酸ドキシラミン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのコハク酸ドキシラミン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 コハク酸ドキシラミンのグローバル主要メーカーには、Teva、CHATTEM、DUCHESNAY、LNK INTERNATIONAL INC、PERRIGO、Viatris (MYLAN)、Osmopharm、PAR PHARM INC、Renata Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 コハク酸ドキシラミン市場は、種類と用途によって区分されます。世界のコハク酸ドキシラミン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 固体、液体 【用途別セグメント】 抗ヒスタミン薬、抗コリン作用薬、鎮静薬、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - コハク酸ドキシラミン製品概要 - 種類別市場（固体、液体） - 用途別市場（抗ヒスタミン薬、抗コリン作用薬、鎮静薬、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のコハク酸ドキシラミン販売量予測2017-2028 - 世界のコハク酸ドキシラミン売上予測2017-2028 - コハク酸ドキシラミンの地域別販売量 - コハク酸ドキシラミンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別コハク酸ドキシラミン販売量 - 主要メーカー別コハク酸ドキシラミン売上 - 主要メーカー別コハク酸ドキシラミン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（固体、液体） - コハク酸ドキシラミンの種類別販売量 - コハク酸ドキシラミンの種類別売上 - コハク酸ドキシラミンの種類別価格 ・用途別市場規模（抗ヒスタミン薬、抗コリン作用薬、鎮静薬、その他） - コハク酸ドキシラミンの用途別販売量 - コハク酸ドキシラミンの用途別売上 - コハク酸ドキシラミンの用途別価格 ・北米市場 - 北米のコハク酸ドキシラミン市場規模（種類別、用途別） - 主要国別のコハク酸ドキシラミン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのコハク酸ドキシラミン市場規模（種類別、用途別） - 主要国別のコハク酸ドキシラミン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のコハク酸ドキシラミン市場規模（種類別、用途別） - 主要国別のコハク酸ドキシラミン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のコハク酸ドキシラミン市場規模（種類別、用途別） - 主要国別のコハク酸ドキシラミン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのコハク酸ドキシラミン市場規模（種類別、用途別） - 主要国別のコハク酸ドキシラミン市場規模（トルコ、サウジアラビア） ・企業情報 Teva、CHATTEM、DUCHESNAY、LNK INTERNATIONAL INC、PERRIGO、Viatris (MYLAN)、Osmopharm、PAR PHARM INC、Renata Ltd ・産業チェーン及び販売チャネル分析 - コハク酸ドキシラミンの産業チェーン分析 - コハク酸ドキシラミンの原材料 - コハク酸ドキシラミンの生産プロセス - コハク酸ドキシラミンの販売及びマーケティング - コハク酸ドキシラミンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - コハク酸ドキシラミンの産業動向 - コハク酸ドキシラミンのマーケットドライバー - コハク酸ドキシラミンの課題 - コハク酸ドキシラミンの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Doxylamine Succinate Market
Due to the COVID-19 pandemic, the global Doxylamine Succinate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Solid accounting for % of the Doxylamine Succinate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Antihistamine segment is altered to an % CAGR throughout this forecast period.
China Doxylamine Succinate market size is valued at US$ million in 2021, while the US and Europe Doxylamine Succinate are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Doxylamine Succinate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Doxylamine Succinate include Teva, CHATTEM, DUCHESNAY, LNK INTERNATIONAL INC, PERRIGO, Viatris (MYLAN), Osmopharm, PAR PHARM INC and Renata Ltd. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Doxylamine Succinate capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Doxylamine Succinate by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Doxylamine Succinate Scope and Segment
Doxylamine Succinate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Doxylamine Succinate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Solid
Liquor
Segment by Application
Antihistamine
Anticholinergic
Sedative
Others
By Company
Teva
CHATTEM
DUCHESNAY
LNK INTERNATIONAL INC
PERRIGO
Viatris (MYLAN)
Osmopharm
PAR PHARM INC
Renata Ltd
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Doxylamine Succinate Product Introduction
1.2 Market by Type
1.2.1 Global Doxylamine Succinate Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Solid
1.2.3 Liquor
1.3 Market by Application
1.3.1 Global Doxylamine Succinate Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Antihistamine
1.3.3 Anticholinergic
1.3.4 Sedative
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Doxylamine Succinate Production
2.1 Global Doxylamine Succinate Production Capacity (2017-2028)
2.2 Global Doxylamine Succinate Production by Region: 2017 VS 2021 VS 2028
2.3 Global Doxylamine Succinate Production by Region
2.3.1 Global Doxylamine Succinate Historic Production by Region (2017-2022)
2.3.2 Global Doxylamine Succinate Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Doxylamine Succinate Sales in Volume & Value Estimates and Forecasts
3.1 Global Doxylamine Succinate Sales Estimates and Forecasts 2017-2028
3.2 Global Doxylamine Succinate Revenue Estimates and Forecasts 2017-2028
3.3 Global Doxylamine Succinate Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Doxylamine Succinate Sales by Region
3.4.1 Global Doxylamine Succinate Sales by Region (2017-2022)
3.4.2 Global Sales Doxylamine Succinate by Region (2023-2028)
3.5 Global Doxylamine Succinate Revenue by Region
3.5.1 Global Doxylamine Succinate Revenue by Region (2017-2022)
3.5.2 Global Doxylamine Succinate Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Doxylamine Succinate Production Capacity by Manufacturers
4.2 Global Doxylamine Succinate Sales by Manufacturers
4.2.1 Global Doxylamine Succinate Sales by Manufacturers (2017-2022)
4.2.2 Global Doxylamine Succinate Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Doxylamine Succinate in 2021
4.3 Global Doxylamine Succinate Revenue by Manufacturers
4.3.1 Global Doxylamine Succinate Revenue by Manufacturers (2017-2022)
4.3.2 Global Doxylamine Succinate Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Doxylamine Succinate Revenue in 2021
4.4 Global Doxylamine Succinate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Doxylamine Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Doxylamine Succinate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Doxylamine Succinate Sales by Type
5.1.1 Global Doxylamine Succinate Historical Sales by Type (2017-2022)
5.1.2 Global Doxylamine Succinate Forecasted Sales by Type (2023-2028)
5.1.3 Global Doxylamine Succinate Sales Market Share by Type (2017-2028)
5.2 Global Doxylamine Succinate Revenue by Type
5.2.1 Global Doxylamine Succinate Historical Revenue by Type (2017-2022)
5.2.2 Global Doxylamine Succinate Forecasted Revenue by Type (2023-2028)
5.2.3 Global Doxylamine Succinate Revenue Market Share by Type (2017-2028)
5.3 Global Doxylamine Succinate Price by Type
5.3.1 Global Doxylamine Succinate Price by Type (2017-2022)
5.3.2 Global Doxylamine Succinate Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Doxylamine Succinate Sales by Application
6.1.1 Global Doxylamine Succinate Historical Sales by Application (2017-2022)
6.1.2 Global Doxylamine Succinate Forecasted Sales by Application (2023-2028)
6.1.3 Global Doxylamine Succinate Sales Market Share by Application (2017-2028)
6.2 Global Doxylamine Succinate Revenue by Application
6.2.1 Global Doxylamine Succinate Historical Revenue by Application (2017-2022)
6.2.2 Global Doxylamine Succinate Forecasted Revenue by Application (2023-2028)
6.2.3 Global Doxylamine Succinate Revenue Market Share by Application (2017-2028)
6.3 Global Doxylamine Succinate Price by Application
6.3.1 Global Doxylamine Succinate Price by Application (2017-2022)
6.3.2 Global Doxylamine Succinate Price Forecast by Application (2023-2028)
7 North America
7.1 North America Doxylamine Succinate Market Size by Type
7.1.1 North America Doxylamine Succinate Sales by Type (2017-2028)
7.1.2 North America Doxylamine Succinate Revenue by Type (2017-2028)
7.2 North America Doxylamine Succinate Market Size by Application
7.2.1 North America Doxylamine Succinate Sales by Application (2017-2028)
7.2.2 North America Doxylamine Succinate Revenue by Application (2017-2028)
7.3 North America Doxylamine Succinate Sales by Country
7.3.1 North America Doxylamine Succinate Sales by Country (2017-2028)
7.3.2 North America Doxylamine Succinate Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Doxylamine Succinate Market Size by Type
8.1.1 Europe Doxylamine Succinate Sales by Type (2017-2028)
8.1.2 Europe Doxylamine Succinate Revenue by Type (2017-2028)
8.2 Europe Doxylamine Succinate Market Size by Application
8.2.1 Europe Doxylamine Succinate Sales by Application (2017-2028)
8.2.2 Europe Doxylamine Succinate Revenue by Application (2017-2028)
8.3 Europe Doxylamine Succinate Sales by Country
8.3.1 Europe Doxylamine Succinate Sales by Country (2017-2028)
8.3.2 Europe Doxylamine Succinate Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Doxylamine Succinate Market Size by Type
9.1.1 Asia Pacific Doxylamine Succinate Sales by Type (2017-2028)
9.1.2 Asia Pacific Doxylamine Succinate Revenue by Type (2017-2028)
9.2 Asia Pacific Doxylamine Succinate Market Size by Application
9.2.1 Asia Pacific Doxylamine Succinate Sales by Application (2017-2028)
9.2.2 Asia Pacific Doxylamine Succinate Revenue by Application (2017-2028)
9.3 Asia Pacific Doxylamine Succinate Sales by Region
9.3.1 Asia Pacific Doxylamine Succinate Sales by Region (2017-2028)
9.3.2 Asia Pacific Doxylamine Succinate Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Doxylamine Succinate Market Size by Type
10.1.1 Latin America Doxylamine Succinate Sales by Type (2017-2028)
10.1.2 Latin America Doxylamine Succinate Revenue by Type (2017-2028)
10.2 Latin America Doxylamine Succinate Market Size by Application
10.2.1 Latin America Doxylamine Succinate Sales by Application (2017-2028)
10.2.2 Latin America Doxylamine Succinate Revenue by Application (2017-2028)
10.3 Latin America Doxylamine Succinate Sales by Country
10.3.1 Latin America Doxylamine Succinate Sales by Country (2017-2028)
10.3.2 Latin America Doxylamine Succinate Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Doxylamine Succinate Market Size by Type
11.1.1 Middle East and Africa Doxylamine Succinate Sales by Type (2017-2028)
11.1.2 Middle East and Africa Doxylamine Succinate Revenue by Type (2017-2028)
11.2 Middle East and Africa Doxylamine Succinate Market Size by Application
11.2.1 Middle East and Africa Doxylamine Succinate Sales by Application (2017-2028)
11.2.2 Middle East and Africa Doxylamine Succinate Revenue by Application (2017-2028)
11.3 Middle East and Africa Doxylamine Succinate Sales by Country
11.3.1 Middle East and Africa Doxylamine Succinate Sales by Country (2017-2028)
11.3.2 Middle East and Africa Doxylamine Succinate Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Overview
12.1.3 Teva Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Teva Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Teva Recent Developments
12.2 CHATTEM
12.2.1 CHATTEM Corporation Information
12.2.2 CHATTEM Overview
12.2.3 CHATTEM Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 CHATTEM Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 CHATTEM Recent Developments
12.3 DUCHESNAY
12.3.1 DUCHESNAY Corporation Information
12.3.2 DUCHESNAY Overview
12.3.3 DUCHESNAY Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 DUCHESNAY Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 DUCHESNAY Recent Developments
12.4 LNK INTERNATIONAL INC
12.4.1 LNK INTERNATIONAL INC Corporation Information
12.4.2 LNK INTERNATIONAL INC Overview
12.4.3 LNK INTERNATIONAL INC Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 LNK INTERNATIONAL INC Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 LNK INTERNATIONAL INC Recent Developments
12.5 PERRIGO
12.5.1 PERRIGO Corporation Information
12.5.2 PERRIGO Overview
12.5.3 PERRIGO Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 PERRIGO Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 PERRIGO Recent Developments
12.6 Viatris (MYLAN)
12.6.1 Viatris (MYLAN) Corporation Information
12.6.2 Viatris (MYLAN) Overview
12.6.3 Viatris (MYLAN) Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Viatris (MYLAN) Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Viatris (MYLAN) Recent Developments
12.7 Osmopharm
12.7.1 Osmopharm Corporation Information
12.7.2 Osmopharm Overview
12.7.3 Osmopharm Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Osmopharm Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Osmopharm Recent Developments
12.8 PAR PHARM INC
12.8.1 PAR PHARM INC Corporation Information
12.8.2 PAR PHARM INC Overview
12.8.3 PAR PHARM INC Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 PAR PHARM INC Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 PAR PHARM INC Recent Developments
12.9 Renata Ltd
12.9.1 Renata Ltd Corporation Information
12.9.2 Renata Ltd Overview
12.9.3 Renata Ltd Doxylamine Succinate Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Renata Ltd Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Renata Ltd Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Doxylamine Succinate Industry Chain Analysis
13.2 Doxylamine Succinate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Doxylamine Succinate Production Mode & Process
13.4 Doxylamine Succinate Sales and Marketing
13.4.1 Doxylamine Succinate Sales Channels
13.4.2 Doxylamine Succinate Distributors
13.5 Doxylamine Succinate Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Doxylamine Succinate Industry Trends
14.2 Doxylamine Succinate Market Drivers
14.3 Doxylamine Succinate Market Challenges
14.4 Doxylamine Succinate Market Restraints
15 Key Finding in The Global Doxylamine Succinate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Doxylamine Succinate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Solid
Table 3. Major Manufacturers of Liquor
Table 4. Global Doxylamine Succinate Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Doxylamine Succinate Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Doxylamine Succinate Production by Region (2017-2022) & (Tons)
Table 7. Global Doxylamine Succinate Production Market Share by Region (2017-2022)
Table 8. Global Doxylamine Succinate Production by Region (2023-2028) & (Tons)
Table 9. Global Doxylamine Succinate Production Market Share by Region (2023-2028)
Table 10. Global Doxylamine Succinate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Doxylamine Succinate Sales by Region (2017-2022) & (Tons)
Table 12. Global Doxylamine Succinate Sales Market Share by Region (2017-2022)
Table 13. Global Doxylamine Succinate Sales by Region (2023-2028) & (Tons)
Table 14. Global Doxylamine Succinate Sales Market Share by Region (2023-2028)
Table 15. Global Doxylamine Succinate Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Doxylamine Succinate Revenue Market Share by Region (2017-2022)
Table 17. Global Doxylamine Succinate Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Doxylamine Succinate Revenue Market Share by Region (2023-2028)
Table 19. Global Doxylamine Succinate Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Doxylamine Succinate Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Doxylamine Succinate Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Doxylamine Succinate Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Doxylamine Succinate Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Doxylamine Succinate Revenue Share by Manufacturers (2017-2022)
Table 25. Doxylamine Succinate Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Doxylamine Succinate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Doxylamine Succinate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doxylamine Succinate as of 2021)
Table 28. Doxylamine Succinate Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Doxylamine Succinate Product Offered
Table 30. Date of Manufacturers Enter into Doxylamine Succinate Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Doxylamine Succinate Sales by Type (2017-2022) & (Tons)
Table 33. Global Doxylamine Succinate Sales by Type (2023-2028) & (Tons)
Table 34. Global Doxylamine Succinate Sales Share by Type (2017-2022)
Table 35. Global Doxylamine Succinate Sales Share by Type (2023-2028)
Table 36. Global Doxylamine Succinate Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Doxylamine Succinate Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Doxylamine Succinate Revenue Share by Type (2017-2022)
Table 39. Global Doxylamine Succinate Revenue Share by Type (2023-2028)
Table 40. Doxylamine Succinate Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Doxylamine Succinate Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Doxylamine Succinate Sales by Application (2017-2022) & (Tons)
Table 43. Global Doxylamine Succinate Sales by Application (2023-2028) & (Tons)
Table 44. Global Doxylamine Succinate Sales Share by Application (2017-2022)
Table 45. Global Doxylamine Succinate Sales Share by Application (2023-2028)
Table 46. Global Doxylamine Succinate Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Doxylamine Succinate Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Doxylamine Succinate Revenue Share by Application (2017-2022)
Table 49. Global Doxylamine Succinate Revenue Share by Application (2023-2028)
Table 50. Doxylamine Succinate Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Doxylamine Succinate Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Doxylamine Succinate Sales by Type (2017-2022) & (Tons)
Table 53. North America Doxylamine Succinate Sales by Type (2023-2028) & (Tons)
Table 54. North America Doxylamine Succinate Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Doxylamine Succinate Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Doxylamine Succinate Sales by Application (2017-2022) & (Tons)
Table 57. North America Doxylamine Succinate Sales by Application (2023-2028) & (Tons)
Table 58. North America Doxylamine Succinate Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Doxylamine Succinate Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Doxylamine Succinate Sales by Country (2017-2022) & (Tons)
Table 61. North America Doxylamine Succinate Sales by Country (2023-2028) & (Tons)
Table 62. North America Doxylamine Succinate Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Doxylamine Succinate Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Doxylamine Succinate Sales by Type (2017-2022) & (Tons)
Table 65. Europe Doxylamine Succinate Sales by Type (2023-2028) & (Tons)
Table 66. Europe Doxylamine Succinate Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Doxylamine Succinate Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Doxylamine Succinate Sales by Application (2017-2022) & (Tons)
Table 69. Europe Doxylamine Succinate Sales by Application (2023-2028) & (Tons)
Table 70. Europe Doxylamine Succinate Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Doxylamine Succinate Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Doxylamine Succinate Sales by Country (2017-2022) & (Tons)
Table 73. Europe Doxylamine Succinate Sales by Country (2023-2028) & (Tons)
Table 74. Europe Doxylamine Succinate Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Doxylamine Succinate Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Doxylamine Succinate Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Doxylamine Succinate Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Doxylamine Succinate Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Doxylamine Succinate Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Doxylamine Succinate Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Doxylamine Succinate Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Doxylamine Succinate Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Doxylamine Succinate Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Doxylamine Succinate Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Doxylamine Succinate Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Doxylamine Succinate Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Doxylamine Succinate Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Doxylamine Succinate Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Doxylamine Succinate Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Doxylamine Succinate Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Doxylamine Succinate Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Doxylamine Succinate Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Doxylamine Succinate Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Doxylamine Succinate Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Doxylamine Succinate Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Doxylamine Succinate Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Doxylamine Succinate Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Doxylamine Succinate Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Doxylamine Succinate Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Doxylamine Succinate Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Doxylamine Succinate Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Doxylamine Succinate Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Doxylamine Succinate Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Doxylamine Succinate Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Doxylamine Succinate Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Doxylamine Succinate Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Doxylamine Succinate Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Doxylamine Succinate Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Doxylamine Succinate Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Doxylamine Succinate Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Doxylamine Succinate Revenue by Country (2023-2028) & (US$ Million)
Table 112. Teva Corporation Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Teva Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Development
Table 117. CHATTEM Corporation Information
Table 118. CHATTEM Description and Major Businesses
Table 119. CHATTEM Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. CHATTEM Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. CHATTEM Recent Development
Table 122. DUCHESNAY Corporation Information
Table 123. DUCHESNAY Description and Major Businesses
Table 124. DUCHESNAY Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. DUCHESNAY Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. DUCHESNAY Recent Development
Table 127. LNK INTERNATIONAL INC Corporation Information
Table 128. LNK INTERNATIONAL INC Description and Major Businesses
Table 129. LNK INTERNATIONAL INC Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. LNK INTERNATIONAL INC Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. LNK INTERNATIONAL INC Recent Development
Table 132. PERRIGO Corporation Information
Table 133. PERRIGO Description and Major Businesses
Table 134. PERRIGO Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. PERRIGO Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. PERRIGO Recent Development
Table 137. Viatris (MYLAN) Corporation Information
Table 138. Viatris (MYLAN) Description and Major Businesses
Table 139. Viatris (MYLAN) Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Viatris (MYLAN) Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Viatris (MYLAN) Recent Development
Table 142. Osmopharm Corporation Information
Table 143. Osmopharm Description and Major Businesses
Table 144. Osmopharm Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Osmopharm Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Osmopharm Recent Development
Table 147. PAR PHARM INC Corporation Information
Table 148. PAR PHARM INC Description and Major Businesses
Table 149. PAR PHARM INC Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. PAR PHARM INC Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. PAR PHARM INC Recent Development
Table 152. Renata Ltd Corporation Information
Table 153. Renata Ltd Description and Major Businesses
Table 154. Renata Ltd Doxylamine Succinate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. Renata Ltd Doxylamine Succinate Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Renata Ltd Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Doxylamine Succinate Distributors List
Table 160. Doxylamine Succinate Customers List
Table 161. Doxylamine Succinate Market Trends
Table 162. Doxylamine Succinate Market Drivers
Table 163. Doxylamine Succinate Market Challenges
Table 164. Doxylamine Succinate Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Doxylamine Succinate Product Picture
Figure 2. Global Doxylamine Succinate Market Share by Type in 2021 & 2028
Figure 3. Solid Product Picture
Figure 4. Liquor Product Picture
Figure 5. Global Doxylamine Succinate Market Share by Application in 2021 & 2028
Figure 6. Antihistamine
Figure 7. Anticholinergic
Figure 8. Sedative
Figure 9. Others
Figure 10. Doxylamine Succinate Report Years Considered
Figure 11. Global Doxylamine Succinate Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 12. Global Doxylamine Succinate Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Doxylamine Succinate Production Market Share by Region (2017-2022)
Figure 14. Global Doxylamine Succinate Production Market Share by Region (2023-2028)
Figure 15. Doxylamine Succinate Production Growth Rate in North America (2017-2028) & (Tons)
Figure 16. Doxylamine Succinate Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 17. Doxylamine Succinate Production Growth Rate in China (2017-2028) & (Tons)
Figure 18. Doxylamine Succinate Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 19. Global Doxylamine Succinate Sales 2017-2028 (Tons)
Figure 20. Global Doxylamine Succinate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Doxylamine Succinate Revenue 2017-2028 (US$ Million)
Figure 22. Global Doxylamine Succinate Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Doxylamine Succinate Sales Market Share by Region (2017-2022)
Figure 24. Global Doxylamine Succinate Sales Market Share by Region (2023-2028)
Figure 25. North America Doxylamine Succinate Sales YoY (2017-2028) & (Tons)
Figure 26. North America Doxylamine Succinate Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Doxylamine Succinate Sales YoY (2017-2028) & (Tons)
Figure 28. Europe Doxylamine Succinate Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Doxylamine Succinate Sales YoY (2017-2028) & (Tons)
Figure 30. Asia-Pacific Doxylamine Succinate Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Doxylamine Succinate Sales YoY (2017-2028) & (Tons)
Figure 32. Latin America Doxylamine Succinate Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Doxylamine Succinate Sales YoY (2017-2028) & (Tons)
Figure 34. Middle East & Africa Doxylamine Succinate Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Doxylamine Succinate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Doxylamine Succinate in the World: Market Share by Doxylamine Succinate Revenue in 2021
Figure 37. Doxylamine Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Doxylamine Succinate Sales Market Share by Type (2017-2028)
Figure 39. Global Doxylamine Succinate Revenue Market Share by Type (2017-2028)
Figure 40. Global Doxylamine Succinate Sales Market Share by Application (2017-2028)
Figure 41. Global Doxylamine Succinate Revenue Market Share by Application (2017-2028)
Figure 42. North America Doxylamine Succinate Sales Market Share by Type (2017-2028)
Figure 43. North America Doxylamine Succinate Revenue Market Share by Type (2017-2028)
Figure 44. North America Doxylamine Succinate Sales Market Share by Application (2017-2028)
Figure 45. North America Doxylamine Succinate Revenue Market Share by Application (2017-2028)
Figure 46. North America Doxylamine Succinate Sales Share by Country (2017-2028)
Figure 47. North America Doxylamine Succinate Revenue Share by Country (2017-2028)
Figure 48. United States Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Doxylamine Succinate Sales Market Share by Type (2017-2028)
Figure 51. Europe Doxylamine Succinate Revenue Market Share by Type (2017-2028)
Figure 52. Europe Doxylamine Succinate Sales Market Share by Application (2017-2028)
Figure 53. Europe Doxylamine Succinate Revenue Market Share by Application (2017-2028)
Figure 54. Europe Doxylamine Succinate Sales Share by Country (2017-2028)
Figure 55. Europe Doxylamine Succinate Revenue Share by Country (2017-2028)
Figure 56. Germany Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 57. France Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Doxylamine Succinate Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Doxylamine Succinate Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Doxylamine Succinate Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Doxylamine Succinate Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Doxylamine Succinate Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Doxylamine Succinate Revenue Share by Region (2017-2028)
Figure 67. China Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 70. India Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Doxylamine Succinate Sales Market Share by Type (2017-2028)
Figure 77. Latin America Doxylamine Succinate Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Doxylamine Succinate Sales Market Share by Application (2017-2028)
Figure 79. Latin America Doxylamine Succinate Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Doxylamine Succinate Sales Share by Country (2017-2028)
Figure 81. Latin America Doxylamine Succinate Revenue Share by Country (2017-2028)
Figure 82. Mexico Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 85. Colombia Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Doxylamine Succinate Sales Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Doxylamine Succinate Revenue Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Doxylamine Succinate Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Doxylamine Succinate Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Doxylamine Succinate Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Doxylamine Succinate Revenue Share by Country (2017-2028)
Figure 92. Turkey Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 94. UAE Doxylamine Succinate Revenue (2017-2028) & (US$ Million)
Figure 95. Doxylamine Succinate Value Chain
Figure 96. Doxylamine Succinate Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed

---